NC 1900
Alternative Names: NC-1900Latest Information Update: 16 Jul 2016
At a glance
- Originator Nippon Chemiphar
- Class Antidementias; Neuroprotectants; Oligopeptides; Pyrrolidinones; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease; Schizophrenia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Alzheimer's-disease in Japan (Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Alzheimer's-disease in USA (Inhalation, Powder)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Schizophrenia in Japan (Injection)